Cystatin C and Creatinine: Interpreting eGFR When Results Disagree

Cystatin C and creatinine are both blood markers used to estimate glomerular filtration rate, or eGFR, which is the usual lab-reported estimate of kidney filtering capacity. They often point in the same direction, but they can disagree because each marker is influenced by different things outside the kidneys. Creatinine is strongly shaped by muscle mass, diet, exercise, and some medicines. Cystatin C is less tied to muscle, but it can be affected by inflammation, steroid use, thyroid status, body fat, smoking, and some illnesses.

A disagreement does not automatically mean one result is “right” and the other is “wrong.” It means the result needs context. The most useful next step is often to look at the combined creatinine-cystatin C eGFR, compare prior results, check urine albumin, and decide whether the difference changes a real clinical decision such as CKD staging, medication dosing, imaging contrast, surgery planning, or referral.

• Creatinine-based eGFR can look better than true kidney function in people with low muscle mass, frailty, amputation, paralysis, severe weight loss, or very low meat intake.
• Creatinine-based eGFR can look worse than true kidney function after heavy exercise, creatine supplements, a large cooked-meat meal, high muscle mass, or medicines that raise creatinine without lowering filtration.
• Cystatin C-based eGFR is often helpful when muscle mass makes creatinine hard to interpret, but cystatin C also has non-kidney influences.
• The combined eGFR using creatinine and cystatin C is usually more accurate than either marker alone, especially near treatment or staging cutoffs.
• CKD is not diagnosed from one eGFR value alone. Persistence for at least 3 months and urine albumin results often matter as much as the number itself.
• Urgent follow-up matters if low eGFR comes with very high potassium, severe dehydration, very low urine output, confusion, chest pain, shortness of breath, or rapidly worsening results.

Table of Contents

• Why Cystatin C and Creatinine Can Disagree
• How the Three eGFR Results Differ
• Common Disagreement Patterns
• When the Combined eGFR Is Most Helpful
• How to Check Whether the Result Is Real
• What Disagreement Means for CKD Staging
• Real-World Examples
• Questions to Discuss With Your Clinician

Why Cystatin C and Creatinine Can Disagree

Creatinine and cystatin C are both filtration markers, but they enter the blood for different reasons. That difference is the main reason two eGFR estimates can disagree.

Creatinine comes from creatine, a compound used by muscles for energy. Your body makes creatinine at a fairly steady rate, but “steady” depends heavily on how much muscle you have and what has happened recently. A muscular person may have a higher creatinine level even with healthy kidneys. A frail older adult may have a deceptively low creatinine level even when kidney filtering is reduced. A large cooked-meat meal, strenuous exercise, creatine supplements, or muscle injury can also raise creatinine for reasons that are not the same as chronic kidney disease.

Cystatin C is a small protein made by most nucleated cells. It is filtered by the kidneys and then broken down in the kidney tubules rather than returned to the blood. Because it is not mainly a muscle marker, it can be useful when creatinine is hard to interpret. That is why cystatin C is often ordered when a person’s creatinine and eGFR result seems out of step with their body size, age, diet, or health situation.

Cystatin C is not perfect. Steroid medicines, thyroid disease, higher body fat, smoking, inflammation, some cancers, and acute illness can affect cystatin C levels. These influences are different from the usual creatinine influences, which is why comparing the two markers can be informative. When both markers agree, confidence usually rises. When they disagree, the difference can point toward muscle-related creatinine bias, cystatin C bias, recent illness, lab variation, or a true kidney issue that needs confirmation.

The disagreement is most important when it changes a decision. A difference between eGFR 92 and 82 usually has less practical impact than a difference between eGFR 62 and 48, or between eGFR 34 and 26. The closer the result is to a threshold for CKD staging, medication dosing, kidney referral, imaging contrast, or surgery planning, the more important it becomes to clarify.

How the Three eGFR Results Differ

Most adults who get a routine kidney panel see a creatinine-based eGFR. Some people also get cystatin C, which may produce two additional estimates. Understanding the names helps avoid confusion.

eGFRcr means estimated GFR based on creatinine. This is the most common result on routine bloodwork. It uses serum creatinine, age, and sex in a validated equation. Modern adult equations no longer use a race coefficient. eGFRcr is convenient, inexpensive, and widely available, but it can be misleading when creatinine does not reflect average muscle production.

eGFRcys means estimated GFR based on cystatin C. This result uses cystatin C, age, and sex. It can be helpful when muscle mass, diet, or creatinine production makes eGFRcr less reliable. It may also add risk information, because higher cystatin C has been linked in studies with kidney and cardiovascular outcomes. Still, cystatin C can be shifted by non-kidney factors.

eGFRcr-cys means estimated GFR using both creatinine and cystatin C. This combined estimate often gives the best overall estimate because the two markers have different weaknesses. If creatinine is biased by muscle mass and cystatin C is influenced by inflammation or steroids, combining them can reduce some of the error from relying on one marker alone.

For a deeper look at how eGFR is reported and staged, see estimated glomerular filtration rate testing. If the confusing part is whether creatinine itself or eGFR should carry more weight, creatinine vs eGFR is a useful companion topic.

A normal or near-normal eGFR is usually reported in mL/min/1.73 m². The “1.73 m²” part means the result is indexed to a standard adult body surface area. That makes results easier to compare across people, but drug dosing sometimes requires a non-indexed estimate in mL/min, especially at very small or very large body size. Clinicians may adjust the number for medication decisions.

Most eGFR equations are estimates, not direct measurements. Even good equations have a margin of error. A single eGFR should be interpreted with the pattern: prior results, current illness, hydration, urine albumin, medications, blood pressure, diabetes status, and whether the result is stable over time.

Common Disagreement Patterns

When cystatin C and creatinine disagree, the direction of the disagreement gives useful clues. The table below shows common patterns, but it cannot diagnose the cause by itself.

Pattern	Plain-language meaning	Common reasons	Usual next step
eGFRcr is higher than eGFRcys	Creatinine suggests better kidney function than cystatin C	Low muscle mass, frailty, amputation, paralysis, low meat intake, chronic illness, or cystatin C elevation from inflammation, steroids, thyroid disease, smoking, adiposity, or cancer	Review body composition and non-kidney cystatin C factors; consider eGFRcr-cys and urine albumin
eGFRcr is lower than eGFRcys	Creatinine suggests worse kidney function than cystatin C	High muscle mass, recent heavy exercise, creatine supplements, cooked meat before testing, muscle injury, or medicines that raise creatinine secretion without true filtration decline	Repeat under steadier conditions; review supplements and medicines; consider eGFRcr-cys
Both eGFRcr and eGFRcys are low	Both markers point toward reduced kidney filtration	Chronic kidney disease, acute kidney injury, dehydration, obstruction, medication effect, or other kidney stress	Check timing, repeat trend, urine albumin, urinalysis, electrolytes, blood pressure, and clinical symptoms
Both are normal but urine albumin is high	Filtering amount looks preserved, but kidney damage may still be present	Diabetes, high blood pressure, glomerular disease, recent intense exercise, fever, infection, or transient albuminuria	Repeat UACR, confirm persistence, and assess kidney and cardiovascular risk

A common example is an older adult with low muscle mass. Their creatinine may look “normal” because they do not produce much creatinine. The creatinine-based eGFR may be 75, while cystatin C-based eGFR may be 48. In that case, cystatin C may reveal kidney risk that creatinine underestimates.

The opposite can happen in a muscular person who lifts heavy weights and takes creatine. Their creatinine may run higher than average, causing eGFRcr to look mildly reduced. Cystatin C may be normal, and the combined estimate may show that kidney filtration is better than the creatinine-only number suggested.

A cystatin C blood test is most helpful when it answers a specific uncertainty. It should not be treated as a separate diagnosis. It is one more lens on kidney filtration.

When the Combined eGFR Is Most Helpful

The combined creatinine-cystatin C eGFR is especially useful when the result sits close to a decision threshold. A small numerical shift can change a label, a dose, a referral, or a safety plan.

Common situations include:

• eGFR near 60, where the result may affect whether CKD is suspected or monitored more closely.
• eGFR near 45 or 30, where staging, medication dosing, and referral decisions may change.
• Possible kidney donation or transplant evaluation, where precision matters more than in routine screening.
• Drug dosing for medicines with narrow safety margins, especially when too high a dose could cause toxicity.
• Major differences in muscle mass, such as frailty, amputation, paralysis, bodybuilding, or severe weight loss.
• Unexpected creatinine results, such as high creatinine in a healthy athletic person or low creatinine in someone who seems clinically unwell.
• Clinical risk that does not match the creatinine eGFR, such as high urine albumin, long-standing diabetes, high blood pressure, or abnormal urine findings.

The combined eGFR is not automatically the final answer in every case. Sometimes one marker is clearly biased. For example, a person taking high-dose steroids during an inflammatory flare may have a cystatin C result that looks worse partly because of steroid and inflammation effects. In that situation, the combined number still helps, but the clinician may weigh the whole pattern rather than follow one calculation blindly.

The combined estimate can also help reduce overreaction. A person may see creatinine-based eGFR of 58 and worry that they have definite stage 3 CKD. If cystatin C and the combined eGFR are both above 60, urine albumin is normal, blood pressure is controlled, and repeat results are stable, the interpretation may be less alarming. The situation still deserves follow-up, but the combined result may prevent unnecessary labeling.

On the other hand, cystatin C can reveal hidden risk. If creatinine-based eGFR is 72 but combined eGFR is 51 in a frail person with diabetes and rising urine albumin, the lower combined estimate may better fit the risk picture. That can lead to closer monitoring, safer medication choices, and earlier kidney-protective treatment discussions.

How to Check Whether the Result Is Real

A disagreement should be handled step by step. The first task is to decide whether the result reflects stable kidney function, a temporary condition, or a marker-specific distortion.

Review the testing conditions

Creatinine can rise after strenuous exercise, dehydration, muscle injury, or a large cooked-meat meal. Creatine supplements can also raise creatinine. If creatinine-based eGFR is unexpectedly low, it is reasonable to ask whether the blood draw happened after a hard workout, heavy meat intake, illness, fasting, vomiting, diarrhea, or poor fluid intake.

Cystatin C can be affected by steroid medicines, thyroid dysfunction, inflammation, smoking, obesity, and some cancers. If cystatin C-based eGFR is unexpectedly low while creatinine looks steady, these factors should be reviewed.

Do not stop prescribed medicines just to “improve” a lab value. Some medicines raise creatinine because they affect creatinine handling, while others truly stress the kidneys. The difference matters, and stopping the wrong drug can be harmful.

Repeat the result when the answer will change care

A repeat test can separate a one-off result from a trend. If the result is only mildly different and the person feels well, clinicians may repeat bloodwork in weeks to months. If the drop is large, new, or paired with symptoms, repeat testing may happen much sooner.

When repeating a test, steady conditions help. Avoid unusually intense exercise for a day or two beforehand unless your clinician says otherwise. Avoid a large cooked-meat meal right before testing. Hydrate normally rather than overdrinking. Tell the clinician about supplements, recent illness, steroid use, thyroid disease, and new medications.

Check urine albumin and the rest of the kidney pattern

Urine albumin-to-creatinine ratio, or UACR, adds information that blood eGFR cannot provide. A UACR below 30 mg/g is generally considered normal or mildly increased. A UACR of 30–300 mg/g is moderately increased. A UACR above 300 mg/g is severely increased. Persistent albuminuria can signal kidney damage even when eGFR is still normal.

Other tests can help place the result in context: potassium, bicarbonate or CO2, calcium, phosphorus, urinalysis, blood pressure, diabetes markers, and sometimes kidney imaging. A broader kidney function blood test panel may show whether the eGFR disagreement is isolated or part of a larger pattern.

What Disagreement Means for CKD Staging

CKD staging uses eGFR categories and albuminuria categories. The eGFR categories are commonly grouped as:

• G1: eGFR 90 or higher, with other evidence of kidney damage if CKD is being diagnosed
• G2: eGFR 60–89, with other evidence of kidney damage if CKD is being diagnosed
• G3a: eGFR 45–59
• G3b: eGFR 30–44
• G4: eGFR 15–29
• G5: eGFR below 15

An eGFR below 60 that persists for at least 3 months can meet the filtration part of CKD criteria. An eGFR above 60 does not rule out CKD if there is persistent albuminuria, abnormal urine sediment, structural kidney disease, genetic kidney disease, or other evidence of kidney damage.

Disagreement matters most around category borders. A creatinine-based eGFR of 58 and cystatin C-based eGFR of 72 may not mean the same thing as creatinine-based eGFR of 41 and cystatin C-based eGFR of 28. Both are disagreements, but the second may change medication dosing, risk level, and referral urgency.

The combined eGFR can be especially helpful for confirming stage G3a when creatinine-based eGFR is 45–59 and there is no albuminuria or other clear evidence of kidney damage. If the combined estimate is above 60 and urine albumin is normal, the risk picture may be different from a persistent combined estimate below 60.

Albuminuria can raise risk even when the eGFR category looks mild. For example, eGFR 68 with UACR 450 mg/g may deserve more concern than eGFR 52 with repeatedly normal UACR, depending on the person’s age, blood pressure, diabetes status, and trend. Kidney risk is not a single-number judgment.

Age also affects interpretation. Average GFR declines with age, but a lower eGFR in an older adult still deserves context. The goal is not to dismiss reduced eGFR as “just aging,” and it is also not to panic over one borderline value. Stability, albuminuria, blood pressure, diabetes, medications, and symptoms determine how seriously the result should be pursued.

Real-World Examples

Low muscle mass makes creatinine look reassuring

A 79-year-old woman has lost weight after a long illness. Her creatinine is 0.82 mg/dL, and her eGFRcr is reported as 70. Because the creatinine looks normal, the result may seem reassuring. Her clinician orders cystatin C because she is frail and takes medicines cleared by the kidneys. Her eGFRcys is 46, and her combined eGFR is 54.

This pattern suggests creatinine may be overestimating kidney function because of low creatinine production. The combined result may be safer for medication review. A normal-looking creatinine should not override the clinical context.

High muscle mass makes creatinine look worse

A 35-year-old man who lifts weights has creatinine of 1.35 mg/dL and eGFRcr of 68. He feels well, has normal blood pressure, normal urinalysis, and no albuminuria. He uses creatine and trained hard the day before the test. Cystatin C is normal, with eGFRcys of 102 and combined eGFR of 86.

This pattern suggests the creatinine-only result may be underestimating kidney function. The next step might be repeating creatinine after avoiding intense exercise and reviewing supplements. The result should still be followed, but it does not carry the same meaning as the same creatinine level in someone with diabetes, albuminuria, and rising blood pressure.

Cystatin C looks worse during inflammation and steroid use

A 52-year-old person with an inflammatory disease starts high-dose steroids. Creatinine-based eGFR remains 78, but cystatin C-based eGFR drops to 52. The combined estimate is 63. Urine albumin is normal, and prior creatinine values have been stable.

This may reflect a mixture of kidney and non-kidney influences. Cystatin C can rise with steroid exposure and inflammation. The combined result is useful, but the timing matters. Repeating the result when inflammation and steroid dose are lower may give a clearer baseline.

Both markers agree that kidney risk is real

A 61-year-old with long-standing diabetes has eGFRcr of 43, eGFRcys of 40, combined eGFR of 41, and UACR of 220 mg/g. Here, the markers agree. The focus moves from “which eGFR is correct?” to kidney protection: blood pressure control, diabetes treatment choices, medication safety, avoiding unnecessary kidney stress, and monitoring progression.

When both markers and urine albumin point in the same direction, the result is more likely to represent a real kidney risk pattern.

Questions to Discuss With Your Clinician

A cystatin C-creatinine disagreement is easier to manage when the conversation focuses on the decision the result is supposed to guide. Good questions include:

• Which eGFR should we use for my situation: creatinine-based, cystatin C-based, or combined?
• Does the difference change my CKD stage, medication doses, imaging plan, or referral need?
• Is my urine albumin-to-creatinine ratio normal, moderately increased, or severely increased?
• Could muscle mass, diet, exercise, supplements, steroids, thyroid disease, inflammation, or recent illness explain the disagreement?
• Should we repeat creatinine and cystatin C under steadier conditions?
• Are any of my medicines affected by kidney function estimates?
• Do I need a non-indexed kidney function estimate for drug dosing because of my body size?
• Is the result stable for at least 3 months, or is this a new change?

Follow-up becomes more urgent when eGFR is falling quickly, potassium is high, urine output drops, swelling worsens, blood pressure is very high, or symptoms appear. Severe weakness, chest pain, fainting, confusion, shortness of breath, severe dehydration, or very low urine output should be treated as urgent medical issues rather than routine lab questions.

For many people, the most reassuring finding is stability: similar results over time, normal urine albumin, normal potassium and bicarbonate, controlled blood pressure, and no abnormal urinalysis findings. For others, cystatin C uncovers risk that creatinine missed. The value of testing both markers is that it can make kidney assessment more personal and less dependent on one imperfect blood marker.

References

• CKD Evaluation and Management 2024 (Guideline)
• eGFR Equations for Adults 2025 (Official Resource)
• Factors Affecting eGFR Accuracy 2025 (Official Resource)
• Clinical Measurements & eGFR Accuracy 2025 (Official Resource)
• Assess Urine Albumin 2012 (Official Resource)

Disclaimer

Cystatin C, creatinine, and eGFR results should be interpreted with your medical history, medications, body size, urine albumin, and prior trends. Do not change prescribed medicines, supplements, fluid intake, or diet based only on one lab result without medical advice. Seek urgent care for severe symptoms, very low urine output, chest pain, severe shortness of breath, confusion, fainting, or a clinician-reported dangerous electrolyte abnormality.